Inspire Medical Systems Ramps Manufacturing Muscle—Will The Inspire V Rollout Be A Game Changer? 

Inspire Medical Systems released its financial results for the first quarter of 2025. The company’s revenue reached $201.3 million, marking a 23% increase compared to the same quarter the previous year. Net income for Q1 was $3 million with a diluted net income of $0.10 per share, showing a notable improvement from the net loss of $10 million and a net loss of $0.34 per share in Q1 2024. Inspire Medical Systems continued to expand the limited market release of the Inspire V system in the U.S., gaining experience and solidifying inventory levels. The company plans to start the full launch of Inspire V this month, which includes improved technical capabilities such as a stable sensing environment and future therapy enhancements like sleep detection. The financial guidance for full-year 2025 remains at a revenue range of $940 million to $955 million, expecting a growth rate of 17% to 19%.